Profile data is unavailable for this security.
About the company
FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
- Revenue in USD (TTM)0.00
- Net income in USD-22.53m
- Incorporated2021
- Employees10.00
- LocationFibrobiologics Inc455 E. Medical Center Blvd, Suite 300HOUSTON 77598United StatesUSA
- Phone+1 (281) 671-5152
- Fax+1 (302) 655-5049
- Websitehttps://fibrobiologics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc | 0.00 | -78.65m | 364.14m | 88.00 | -- | 1.74 | -- | -- | -1.86 | -1.86 | 0.00 | 4.22 | 0.00 | -- | -- | 0.00 | -35.66 | -- | -37.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -30.03 | -- | -- | -- |
| Organogenesis Holdings Inc | 435.47m | 5.82m | 364.57m | 862.00 | 63.25 | 1.31 | 17.17 | 0.8372 | 0.0435 | 0.0435 | 3.28 | 2.11 | 0.9628 | 4.08 | 4.63 | 505,190.30 | 1.29 | 5.46 | 1.56 | 6.90 | 75.07 | 74.94 | 1.34 | 4.81 | 2.41 | 8.78 | 0.1955 | 0.00 | -3.94 | 17.49 | -68.16 | -- | 67.34 | -- |
| Biomea Fusion Inc | 0.00 | -127.27m | 378.14m | 110.00 | -- | 2.79 | -- | -- | -3.57 | -3.57 | 0.00 | 3.77 | 0.00 | -- | -- | 0.00 | -90.54 | -- | -107.35 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -43.29 | -- | -- | -- |
| Anika Therapeutics Inc | 169.26m | -76.83m | 380.35m | 357.00 | -- | 1.82 | -- | 2.25 | -5.24 | -5.24 | 11.54 | 14.07 | 0.5616 | 1.42 | 5.40 | 474,120.40 | -25.49 | -5.41 | -28.16 | -5.87 | 61.96 | 60.70 | -45.39 | -12.60 | 3.85 | -- | 0.00 | -- | 6.67 | 9.56 | -456.34 | -- | 3.11 | -- |
| enGene Holdings Inc | 0.00 | -106.80m | 387.65m | 33.00 | -- | 3.27 | -- | -- | -4.60 | -4.60 | 0.00 | 2.69 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.37 | 0.2653 | -- | -- | -- | -260.87 | -- | -- | -- |
| Terns Pharmaceuticals Inc | 0.00 | -91.06m | 388.71m | 66.00 | -- | 1.64 | -- | -- | -1.26 | -1.26 | 0.00 | 3.66 | 0.00 | -- | -- | 0.00 | -33.23 | -41.34 | -34.55 | -45.70 | -- | -- | -- | -31,010.30 | -- | -- | 0.00 | -- | -- | -- | -49.49 | -- | -26.60 | -- |
| Lenz Therapeutics Inc | 0.00 | -117.37m | 390.42m | 6.00 | -- | 1.97 | -- | -- | -15.88 | -15.88 | 0.00 | 7.77 | 0.00 | -- | -- | 0.00 | -44.51 | -- | -47.51 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.35 | -- | -- | -- |
| Jasper Therapeutics Inc | 0.00 | -63.93m | 391.62m | 45.00 | -- | 3.46 | -- | -- | -5.60 | -5.60 | 0.00 | 7.51 | 0.00 | -- | -- | 0.00 | -48.30 | -- | -51.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.06 | -- | -- | -- |
| Contineum Therapeutics Inc | 50.00m | 19.13m | 394.08m | 31.00 | 20.13 | -- | 20.36 | 7.88 | 0.7611 | 0.7611 | 1.99 | 4.66 | -- | -- | -- | 1,612,903.00 | -- | -- | -- | -- | -- | -- | 38.25 | -- | -- | -- | 0.00 | -- | -- | -- | 193.68 | -- | -- | -- |
| Fibrobiologics Inc | 0.00 | -22.53m | 398.52m | 10.00 | -- | -- | -- | -- | -1.03 | -1.03 | 0.00 | -0.1181 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -272.15 | -- | -- | -- |
| ACELYRIN Inc | 0.00 | -240.16m | 407.99m | 130.00 | -- | 0.6324 | -- | -- | -2.59 | -2.59 | 0.00 | 6.52 | 0.00 | -- | -- | 0.00 | -48.23 | -- | -52.78 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -489.21 | -- | -- | -- |
| Esperion Therapeutics Inc | 229.74m | -86.51m | 409.23m | 240.00 | -- | -- | -- | 1.78 | -1.00 | -1.00 | 1.76 | -1.57 | 0.7353 | 0.7415 | 5.05 | 957,250.00 | -27.69 | -69.45 | -47.42 | -101.81 | 81.85 | -- | -37.65 | -147.44 | 1.78 | -0.6581 | -- | -- | 54.14 | -- | 10.45 | -- | -- | -- |
| Fate Therapeutics Inc | 6.48m | -190.05m | 418.90m | 181.00 | -- | 0.9828 | -- | 64.67 | -1.92 | -1.92 | 0.0653 | 3.74 | 0.0108 | -- | 0.9024 | 35,790.05 | -31.67 | -31.82 | -34.36 | -36.05 | -- | -- | -2,933.79 | -359.33 | -- | -- | 0.00 | -- | -34.03 | 68.05 | 42.88 | -- | 21.72 | -- |
| Theravance Biopharma Inc | 61.51m | -44.77m | 419.22m | 99.00 | -- | 2.04 | -- | 6.82 | -0.861 | -0.861 | 1.19 | 4.22 | 0.1352 | -- | 4.57 | 621,313.10 | -9.84 | -40.51 | -10.39 | -48.50 | -- | -- | -72.78 | -305.27 | -- | -- | 0.00 | -- | 11.84 | -0.9956 | 40.54 | -- | -19.24 | -- |
| Editas Medicine Inc | 69.41m | -166.13m | 427.64m | 265.00 | -- | 1.45 | -- | 6.16 | -2.10 | -2.10 | 0.8765 | 3.58 | 0.1535 | -- | 285.04 | 261,913.20 | -36.74 | -29.85 | -42.55 | -33.19 | -- | -- | -239.36 | -347.71 | -- | -- | 0.00 | -- | 296.32 | 19.59 | 30.49 | -- | -0.1477 | -- |
| Verve Therapeutics Inc | 16.05m | -196.83m | 435.78m | 255.00 | -- | 0.7461 | -- | 27.15 | -2.87 | -2.87 | 0.2309 | 6.96 | 0.0235 | -- | 4.48 | 62,937.25 | -28.80 | -- | -30.24 | -- | -- | -- | -1,226.43 | -- | -- | -- | 0.00 | -- | 505.77 | -- | -27.12 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Fibrobiologics Inc's reporting currency: US Dollar USD
1.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Millennium Management LLCas of 31 Mar 2024 | 209.23k | 0.64% |
| HRT Financial LLCas of 31 Mar 2024 | 57.34k | 0.18% |
| Marshall Wace LLPas of 31 Mar 2024 | 52.03k | 0.16% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 2024 | 30.42k | 0.09% |
| ExodusPoint Capital Management LPas of 31 Mar 2024 | 25.59k | 0.08% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 22.63k | 0.07% |
| NewEdge Advisors LLCas of 31 Mar 2024 | 17.91k | 0.06% |
| Point72 Asset Management LPas of 31 Mar 2024 | 15.92k | 0.05% |
| Balyasny Asset Management LPas of 31 Mar 2024 | 14.25k | 0.04% |
| Geode Capital Management LLCas of 31 Mar 2024 | 10.99k | 0.03% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
